These modifications, known to suppress gene expression, may contribute to the observed reduction in C9orf72 mRNA levels in the frontal cortices and cerebella of ALS-affected patients (Belzil et al., 2013). This evidence concerns the gene C9orf72 and amyotrophic lateral sclerosis.